Table 4.

Hormonal dynamics in FHA women with and without PCOM who responded to three months of pulsatile GnRH treatment

	FHA patients without PCOM (n = 12)			FHA patients with PCOM (n = 7)
	Baseline	3-months follow-up	p	Baseline	3-months follow-up	p
FSH (mIU/mL)	5.1 (1.6;7.5)	6.9 (3.7;8.4)	0.002	4.8 (4.0;6.5)	5.0 (4.2;5.4)	0.933
LH (mIU/mL)	1.5 (0.3;4.9)	4.6 (3.8;6.3)	0.016	3.0 (0.6;6.9)	7.3 (6.6;9.1)	0.018
Estradiol (pg/mL)	21 (9;36)	46 (38;55)	0.005	24 (11;41)	56 (49;66)	0.028
AMH (ng/mL)	1.69 (1.58;2.20)	2.02 (1.81;2.49)	0.002	4.9 (3.6;7.4)	5.2 (3.6;6.3)	0.237